BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024 December 6, 2023 GlobeNewswire Source: Medical Share on Facebook Share Share on TwitterTweet Share on Google Plus Share Share on Pinterest Share Share on LinkedIn Share Share on Digg Share